Chasmanthera dependens
Chasmanthera dependens · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Chasmanthera dependens is a botanical species recognized for its various medicinal applications in traditional healing practices. The plant contains the chemical compound oxoglaucine, which plays a significant role in its biological activity. Researchers often utilize the leaf and stem, particularly through preparations like crude extracts and stem bark water extracts, to study its therapeutic potential. These extracts have been investigated for their ability to influence the immune response and address conditions such as enterovirus. Furthermore, the plant is frequently studied for its potential effectiveness in managing bone fractures and arthritis.
- Synonyms
- Chasmanthera Welwitschii
- Common names
- Not available
- Family
- Menispermaceae
- Distribution
- Not available
- Plant Parts
- Leaf · Stem
Classification
Common Names
Chasmanthera dependens is a unique botanical species known by several different regional and linguistic names. In certain contexts, it is referred to by the common name Kugiei. It is also recognized by the descriptive title chazmantera ovísajúca. Furthermore, the plant carries the Russian designation Хасмантера свисающая. These diverse naming conventions highlight the various ways this specific plant is identified across different cultures and languages.
Sources: Catalogue of Life (COL)
Synonyms
Chasmanthera dependens is a botanical species that is frequently identified in scientific literature by its synonym, Chasmanthera welwitschii. This nomenclature reflects the evolving nature of taxonomic classifications within the plant kingdom. Researchers often encounter both names when studying the specific characteristics and habitats of this particular organism. Understanding these synonymous relationships is essential for maintaining accuracy in biological databases and field studies. Consequently, recognizing the connection between these two names ensures seamless communication among botanists worldwide.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Chasmanthera dependens is a distinctive member of the kingdom Plantae. This species belongs to the genus Chasmanthera and is categorized within the family Menispermaceae. Taxonomically, it is classified under the order Ranunculales, reflecting its evolutionary lineage. Furthermore, the plant is situated within the class Equisetopsida. These biological relationships highlight the specific placement of this organism within the complex plant kingdom.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Ranunculales |
| Family | Menispermaceae |
| Genus | Chasmanthera |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Chasmanthera dependens is a plant species with a notable presence across several regions of the African continent. Its distribution extends through East Tropical Africa, where it can be found in the landscapes of Kenya, Tanzania, and Uganda. Beyond the eastern regions, the species also inhabits parts of Northeast Tropical Africa. Specifically, it has been documented growing within the borders of Chad and Eritrea. This wide-reaching range highlights the plant's ability to adapt to diverse tropical environments.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Chasmanthera dependens is characterized by an obligatory climbing habit that allows it to ascend through its environment. This specialized growth strategy enables the plant to reach a maximum height of approximately 5 meters.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Chasmanthera dependens is a notable medicinal plant recognized for containing the phytochemical oxoglaucine. As a member of the oxoaporphine class of alkaloids, this compound offers significant biological potential for modern drug discovery. Research indicates that oxoglaucine possesses a wide array of therapeutic activities, ranging from anti-inflammatory effects to anticancer properties. Specifically, it has shown promise in treating conditions such as arthritis, osteoarthritis, and various viral infections. Understanding these chemical relationships is essential for scientists working to harness the medicinal power of natural products.
Conditions
Chasmanthera dependens is utilized in traditional medicine for the treatment of bone fractures, wounds, and sprains. In the northern region of the Republic of Benin, this plant is specifically recognized by healers for its ability to promote healing and manage musculoskeletal disorders. Scientific research further demonstrates that extracts from the species possess antileishmanial activity against Leishmania major promastigotes. Additionally, the phytochemical oxoglaucine, which is isolated from this plant, exhibits significant antiaggregation potential. These diverse medicinal properties highlight the plant's importance in treating both physical injuries and various biological processes.
Preparations
Chasmanthera dependens is prepared as various types of extracts for pharmacological testing. Specifically, the plant is prepared as crude extracts to assay for antileishmanial activity in cell-free cultures and infected macrophages. Research also indicates that Chasmanthera dependens is prepared as a stem bark water extract. These different forms of extracts are utilized to evaluate the plant's potential immunomodulative effects. Through these preparation methods, the plant's inhibitory concentrations and levels of cytotoxicity are determined.
Parts used
Chasmanthera dependens is a botanical species characterized by several distinct morphological components, including the leaf and the stem. Scientific investigations have utilized methanol extracts derived from the dried leaves to demonstrate significant anti-inflammatory and analgesic properties. Additionally, researchers have examined the medicinal potential of the plant by utilizing water extracts taken from the stem bark. These studies indicate that the plant possesses notable antileishmanial and immunomodulative effects against Leishmania major. Ultimately, the diverse parts of Chasmanthera dependens serve as vital subjects for exploring new pharmacological applications.